Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An observation, real-life trial to assess vildagliptin, vs oral antihyperglycaemics, in combination with oral antihyperglycaemic monotherapy in patients with type 2 diabetes mellitus inqdeuately controlled with one oral antihyperglycaemic.

Next Previous
Trial Profile

An observation, real-life trial to assess vildagliptin, vs oral antihyperglycaemics, in combination with oral antihyperglycaemic monotherapy in patients with type 2 diabetes mellitus inqdeuately controlled with one oral antihyperglycaemic.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jan 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Vildagliptin (Primary) ; Antihyperglycaemics; Metformin; Sulfonylureas
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms EDGE

    • Most Recent Events

    • 06 Dec 2019 Results, assessing recruitment patterns on gender basis from the data of two clinical trials (VERIFY and EDGE), presented at the 2019 Congress of the International Diabetes Federation
    • 22 May 2019 Data from this study was employed to compare the outcomes obtained with general Framingham against end-point Framingham (EPF) equations; result presented at the 24th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
    • 01 Aug 2017 Results of a post-hoc analysis published in the Diabetes Therapy.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top